Patent ID: 8779158

Claim:
A compound according to formula (I) or a stereochemically isomeric form thereof, wherein Z is C 1-6 alkyl substituted with one or more substituents independently selected from the group consisting of hydroxyl, R 1 R 2 N—C(═O)—, R 3 O—C(═O)— and halo; Q is 2,2-difluorobenzodioxol-5-yl, unsubstituted phenyl or phenyl substituted with one, two or three substituents independently selected from the group consisting of halo, hydroxyl, cyano, C 1-6 alkyl, C 1-6 alkyl-O—, polyhaloC 1-6 alkyl and polyhaloC 1-6 alkyl-O—; L is phenyl, pyridinyl or benzodioxanyl, each optionally substituted with one, two or more substituents independently selected from the group consisting of halo, cyano, C 1-6 alkyl, C 1-6 alkyl-O—, C 1-6 alkyl-S—, polyhaloC 1-6 alkyl, polyhaloC 1-6 alkyl-O—, mono- and di(C 1-6 alkyl)amino, pyrrolidinyl, piperidinyl, morpholinyl, CH 3 O—C 1-6 alkyl-NH—, HO—C 1-6 alkyl-NH—, C 3-6 cycloalkyl, C 3-6 cycloalkyl-NH—, C 3-6 cycloalkyl-C 1-6 alkyl-NH—, C 1-6 alkyl-O—C 1-6 alkyl-, methoxycarbonyl and C 3-6 cycloalkyl-O—C 1-6 alkyl-; R 1 and R 2 each independently represent hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-4 -alkyl-O—C 1-6 alkyl or C 3-6 cycloalkylC 1-6 alkyl; or R 1 and R 2 taken together with the nitrogen atom to which they are attached form a heterocyclic radical selected from the group consisting of pyrrolidinyl, piperidinyl, and morpholinyl, each optionally substituted with one, two or three substituents each independently selected from the group consisting of halo, hydroxy and C 1-6 alkyl; R 3 is hydrogen or C 1-3 alkyl; or a pharmaceutically acceptable addition salt, or a hydrate or a solvate thereof.